The COVID-19 Diagnostic Kits theme has 9 member stock(s) today, with an average return of +0.0%. The leading stock is 휴마시스 (+3.0%, trading value 144,837,808).
In vitro diagnostic healthcare theme, receiving short-term earnings momentum expectations and attention when news of novel variant virus resurgences is reported.
| Stock | Price | Return | Trading Value |
|---|---|---|---|
| 휴마시스 | 2,920 | +3.0% | 144,837,808 |
| 수젠텍 | 4,630 | +2.2% | 2,252,114,706 |
| 씨젠 | 31,950 | +1.3% | 11,143,340,300 |
| 진매트릭스 | 1,600 | +1.1% | 197,188,217 |
| 바디텍메드 | 9,610 | +0.1% | 188,255,795 |
| 랩지노믹스 | 500 | 0.0% | 0 |
| 엑세스바이오 | 2,470 | -0.2% | 241,902,105 |
| 씨티씨바이오 | 3,020 | -2.6% | 90,423,020 |
| 바이오니아 | 9,500 | -4.7% | 5,775,355,200 |
This page's data is for reference only and is not investment advice. Actual market data may differ.